Medical research

Extra chromosome 21 removed from Down syndrome cell line

(Medical Xpress)—University of Washington scientists have succeeded in removing the extra copy of chromosome 21 in cell cultures derived from a person with Down syndrome, a condition in which the body's cells contain three ...

Oncology & Cancer

RNA-based therapy brings new hope for an incurable blood cancer

Three thousand new cases of Mantle Cell Lymphoma (MCL), a form of blood cancer, appear in the United States each year. With a median survival span of only five to seven years, according to the Leukemia and Lymphoma Society, ...

Oncology & Cancer

Avastin disappoints against ovarian cancer

Avastin, the blockbuster drug that just lost approval for treating breast cancer, now looks disappointing against ovarian cancer, too. Two studies found it did not improve survival for most of these patients and kept their ...

Oncology & Cancer

Ecstasy derivative targets blood cancers

(Medical Xpress) -- A team of UWA researchers have found they may be able to alter the club drug ‘ecstasy’ to kill certain types of blood cancers at the same time boosting the potency and reducing the psychoactivity.

Oncology & Cancer

Arthritis linked to blood cancer mutations

A team of Adelaide and U.S. researchers has discovered a link between a less common form of rheumatoid arthritis and gene mutations found in blood cancer.

page 8 from 40